Financial statements Neuron
Balance sheet data of NEURON
|
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 7 886 705,43 | 9 497 519,50 | 11 490 904,84 | 15 652 932,64 | 17 860 245,69 |
| A. Fixed assets | 5 945 536,78 | 6 386 972,72 | 7 845 249,08 | 11 355 394,79 | 14 237 890,26 |
| B. Current assets | 1 941 168,65 | 3 110 546,78 | 3 645 655,76 | 4 297 537,85 | 3 622 355,43 |
| C. Share capital contributions (basic funds) | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - |
| Total liabilities | 7 886 705,43 | 9 497 519,50 | 11 490 904,84 | 15 652 932,64 | 17 860 245,69 |
| A. Equity | 5 185 376,38 | 5 993 786,27 | 7 249 358,76 | 9 144 756,93 | 10 511 329,01 |
| B. Liabilities and provisions for liabilities | 2 701 329,05 | 3 503 733,23 | 4 241 546,08 | 6 508 175,71 | 7 348 916,68 |
| I. Long-term liabilities | 1 027 333,12 | 1 410 000,00 | 1 152 751,92 | 2 630 267,05 | 3 193 164,35 |
| II. Short-term liabilities | 1 614 365,01 | 1 749 827,69 | 2 790 492,69 | 3 148 015,22 | 3 585 695,46 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.